Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Home Diagnostics, Inc.
Home Diagnostics Announces New $5 Million Share Repurchase Program
January 25th, 2009
Home Diagnostics, Inc. (Nasdaq:HDIX), leading manufacturer and marketer of diabetes testing supplies, announced that its Board of Directors authorized the company to repurchase up to $5 million of its common stock to be funded with available cash. This program follows two stock repurchase programs of $5 million each that were completed in 2007 and 2008. All purchases will be made in the open market or in privately negotiated transactions, subject to market conditions and other corporate considerations and in accordance with applicable insider trading and other securities laws and regulations. About Home Diagnostics, Inc. Based in Fort Lauderdale, Florida, Home...
Source: Pharma Investments, Ventures & Law Weekly (2009-01-25)
|
